Federated Hermes’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $396K | Buy |
4,945
+800
| +19% | +$66K | ﹤0.01% | 1359 |
|
|
2025
Q4 | $353K | Sell |
4,145
-85
| -2% | -$6.98K | ﹤0.01% | 1396 |
|
|
2025
Q3 | $329K | Buy |
4,230
+1,677
| +66% | +$131K | ﹤0.01% | 1422 |
|
|
2025
Q2 | $200K | Sell |
2,553
-39
| -2% | -$2.91K | ﹤0.01% | 1497 |
|
|
2025
Q1 | $188K | Buy |
2,592
+1,456
| +128% | +$104K | ﹤0.01% | 1498 |
|
|
2024
Q4 | $84.1K | Sell |
1,136
-2,068
| -65% | -$145K | ﹤0.01% | 1589 |
|
|
2024
Q3 | $211K | Buy |
3,204
+1,580
| +97% | +$115K | ﹤0.01% | 1471 |
|
|
2024
Q2 | $150K | Sell |
1,624
-201
| -11% | -$17.8K | ﹤0.01% | 1519 |
|
|
2024
Q1 | $174K | Sell |
1,825
-178
| -9% | -$15K | ﹤0.01% | 1519 |
|
|
2023
Q4 | $153K | Sell |
2,003
-10,491
| -84% | -$730K | ﹤0.01% | 1546 |
|
|
2023
Q3 | $866K | Sell |
12,494
-6,879
| -36% | -$553K | ﹤0.01% | 1161 |
|
|
2023
Q2 | $1.83M | Buy |
19,373
+6,485
| +50% | +$564K | ﹤0.01% | 987 |
|
|
2023
Q1 | $1.07M | Buy |
12,888
+9,016
| +233% | +$709K | ﹤0.01% | 1153 |
|
|
2022
Q4 | $289K | Sell |
3,872
-740,680
| -99% | -$57.1M | ﹤0.01% | 1495 |
|
|
2022
Q3 | $61.5M | Buy |
744,552
+1,041
| +0.1% | +$100K | 0.18% | 141 |
|
|
2022
Q2 | $70.7M | Sell |
743,511
-56,616
| -7% | -$5.86M | 0.19% | 138 |
|
|
2022
Q1 | $94.2M | Sell |
800,127
-24,807
| -3% | -$2.78M | 0.21% | 129 |
|
|
2021
Q4 | $107M | Buy |
824,934
+866
| +0.1% | +$101K | 0.2% | 140 |
|
|
2021
Q3 | $93.3M | Buy |
824,068
+1,623
| +0.2% | +$185K | 0.18% | 160 |
|
|
2021
Q2 | $85.2M | Buy |
822,445
+439
| +0.1% | +$41.4K | 0.16% | 178 |
|
|
2021
Q1 | $68.8M | Sell |
822,006
-249
| -0% | -$21.1K | 0.13% | 202 |
|
|
2020
Q4 | $75M | Sell |
822,255
-403
| -0% | -$33.4K | 0.15% | 172 |
|
|
2020
Q3 | $65.7M | Sell |
822,658
-12,012
| -1% | -$937K | 0.15% | 158 |
|
|
2020
Q2 | $57.7M | Sell |
834,670
-16,433
| -2% | -$1.17M | 0.14% | 165 |
|
|
2020
Q1 | $53.5M | Sell |
851,103
-33,474
| -4% | -$2.41M | 0.16% | 149 |
|
|
2019
Q4 | $68.8M | Buy |
884,577
+15,615
| +2% | +$1.22M | 0.15% | 157 |
|
|
2019
Q3 | $63.7M | Sell |
868,962
-78,276
| -8% | -$5.5M | 0.16% | 152 |
|
|
2019
Q2 | $58.3M | Sell |
947,238
-90,303
| -9% | -$5.46M | 0.14% | 161 |
|
|
2019
Q1 | $66.2M | Sell |
1,037,541
-30,615
| -3% | -$1.75M | 0.16% | 133 |
|
|
2018
Q4 | $54.5M | Sell |
1,068,156
-937,917
| -47% | -$47.5M | 0.15% | 145 |
|
|
2018
Q3 | $116M | Sell |
2,006,073
-116,661
| -5% | -$5.71M | 0.27% | 74 |
|
|
2018
Q2 | $103M | Sell |
2,122,734
-302,601
| -12% | -$14.1M | 0.3% | 78 |
|
|
2018
Q1 | $113M | Sell |
2,425,335
-95,976
| -4% | -$4.17M | 0.33% | 64 |
|
|
2017
Q4 | $94.7M | Sell |
2,521,311
-1,545
| -0.1% | -$56.7K | 0.27% | 74 |
|
|
2017
Q3 | $91.9M | Buy |
2,522,856
+191,763
| +8% | +$7.31M | 0.26% | 75 |
|
|
2017
Q2 | $91.9M | Sell |
2,331,093
-17,055
| -0.7% | -$623K | 0.26% | 67 |
|
|
2017
Q1 | $73.6M | Buy |
2,348,148
+477,114
| +26% | +$14.9M | 0.21% | 87 |
|
|
2016
Q4 | $58.4M | Buy |
1,871,034
+891,966
| +91% | +$28.9M | 0.18% | 113 |
|
|
2016
Q3 | $39.3M | Sell |
979,068
-124,233
| -11% | -$4.68M | 0.11% | 142 |
|
|
2016
Q2 | $36.7M | Buy |
1,103,301
+962,562
| +684% | +$32.9M | 0.11% | 151 |
|
|
2016
Q1 | $4.14M | Buy |
140,739
+131,976
| +1,506% | +$3.64M | 0.01% | 597 |
|
|
2015
Q4 | $230K | Sell |
8,763
-368,799
| -98% | -$9.58M | ﹤0.01% | 1455 |
|
|
2015
Q3 | $8.95M | Buy |
377,562
+237,792
| +170% | +$5.74M | 0.03% | 456 |
|
|
2015
Q2 | $3.32M | Sell |
139,770
-150,504
| -52% | -$3.4M | 0.01% | 742 |
|
|
2015
Q1 | $6.89M | Buy |
290,274
+36,672
| +14% | +$823K | 0.02% | 530 |
|
|
2014
Q4 | $5.38M | Buy |
253,602
+204,330
| +415% | +$4.1M | 0.02% | 588 |
|
|
2014
Q3 | $839K | Buy |
49,272
+6,960
| +16% | +$110K | ﹤0.01% | 1238 |
|
|
2014
Q2 | $605K | Buy |
42,312
+21,984
| +108% | +$298K | ﹤0.01% | 1308 |
|
|
2014
Q1 | $251K | Buy |
20,328
+2,568
| +14% | +$29.6K | ﹤0.01% | 1469 |
|
|
2013
Q4 | $195K | Buy |
17,760
+6,954
| +64% | +$78.4K | ﹤0.01% | 1487 |
|
|
2013
Q3 | $125K | Buy |
10,806
+9,000
| +498% | +$105K | ﹤0.01% | 1529 |
|
|
2013
Q2 | $20K | Buy |
+1,806
| New | +$21.4K | ﹤0.01% | 1652 |
|
Other funds holding EW
VCM
VPM
Federated Hermes's EW Position: Q1 2026 in Review
Federated Hermes increased its Edwards Lifesciences (EW) stake by 19% in Q1 2026, buying an estimated $66K and bringing the position to 4,945 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #1359.
Federated Hermes first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $116M in Q3 2018. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Federated Hermes held 4,945 shares of Edwards Lifesciences worth $396K as of Q1 2026.
- Federated Hermes bought 800 Edwards Lifesciences shares in Q1 2026, an estimated $66K.
- Edwards Lifesciences made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1359 holding.
- Federated Hermes first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Federated Hermes's Edwards Lifesciences position peaked at $116M in Q3 2018.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.